The Investment Column: MDIS
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.SHARES IN MDIS, the software engineer formerly known as McDonnell Information Systems, tumbled 20 per cent yesterday, after the company posted another profit warning.
MDIS investors were similarly burnt only five months ago, and shortly after the company's flotation in 1994. The company says that it is being squeezed by a shrinking enterprise resource planning software market.
Should MDIS investors hold on for recovery?
MDIS helps companies centralise their computer software, enabling greater sharing of information around the organisation. It has a basic platform of proprietary software to which it adds additional features tailored to a particular company. The problem is that it is being edged out of its markets - traditionally mid-size companies - by larger rivals such as the German-based SAP, and Baan of Holland. They have exhausted their large company customer base and unable to expand horizontally are expanding vertically.
Their experience, reputation and size makes them formidable competitors and only companies with niches, such as specialist expertise in insurance software, will be able to survive. The company says first half losses at Glovia, its joint venture with Fujitsu of Japan, will exceed profits in its UK operations. The shares, which closed down 5.25p at 20.5p, are already well down on their 12 month high of 43.5p.
Holders of the stock may be tempted to hang on for a bid. However, with companies freezing IT spending ahead of the millennium, the outlook for MDIS remains weak and the shares could fall further.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments